TNGX Tango Therapeutics
- 8.280
- -0.340-3.94%
- 8.500
- +0.220+2.66%
Tango Therapeutics News
Tango Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Third Rock Ventures IV, L.P.
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Tango Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Third Rock Ventures IV, L.P.
Tango Therapeutics | 4: Statement of changes in beneficial ownership of securities- Davis Aaron I.
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Tango Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Third Rock Ventures IV, L.P.
Tango Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Third Rock Ventures IV, L.P.(15.9%),Third Rock Ventures GP IV, L.P.(15.9%), etc.
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Tango Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Third Rock Ventures IV, L.P.
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Tango Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Third Rock Ventures IV, L.P.
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Tango Therapeutics | 10-Q: Q2 2024 Earnings Report
Tango Therapeutics | 8-K: Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
Tango Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Third Rock Ventures IV, L.P.
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Tango Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Third Rock Ventures IV, L.P.
Analysis
Price Target
No Data
No Data